CN Patent

CN101115761A — 2,4-嘧啶二胺化合物的前药及其应用

Assigned to Rigel Pharmaceuticals Inc · Expires 2008-01-30 · 18y expired

What this patent protects

本发明提供了生物活性2，4－嘧啶二胺化合物的前药，含有该前药的组合物，合成该前药的中间体和方法以及将该前药用于各种应用的方法。

USPTO Abstract

本发明提供了生物活性2，4－嘧啶二胺化合物的前药，含有该前药的组合物，合成该前药的中间体和方法以及将该前药用于各种应用的方法。

Drugs covered by this patent

fostamatinib-disodium (FOSTAMATINIB DISODIUM)

Patent Metadata

Patent number: CN101115761A
Jurisdiction: CN
Classification: —
Expires: 2008-01-30
Drug substance claim: No
Drug product claim: No
Assignee: Rigel Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.